ZS

Incentive compensation (IC) is no longer only an execution-focused workstream where accuracy is the primary goal—it’s becoming a strategic lever for driving field performance, enabling faster decision-making and adapting to a rapidly changing market. As life sciences organizations face growing complexity in IC design and delivery, many are turning to AI and advanced analytics to modernize how they operate.

In this session, we’ll explore how AI is being applied across the IC life cycle—from smarter plan design and predictive scenario modeling to real-time payout insights and self-service execution. We’ll also demonstrate how a commercial platform like ZAIDYN® brings these capabilities together to scale IC with speed, transparency and precision, delivering an enhanced user experience with simplicity and ease of use.

What you'll learn:

• How AI-powered IC becomes a catalyst for revenue growth, talent retention and market responsiveness
• Insights-driven approaches supported by data to enable confident, real-time choices across commercial teams
• Real-world life sciences successes with measurable improvements in speed, data quality and scalability

Speakers:

Michael Cass, Principal, Incentive Compensation, ZS
Michael Cass is a principal at ZS and leads ZS’s incentive compensation practice. He brings over two decades of experience helping clients address all aspects of incentive compensation, including plan design, goal setting, administration and reporting. His work spans a variety of therapeutic areas, including oncology, immunology and rare diseases.

Amey Deorukhkar, Principal, Incentive Compensation, ZS
Amey Deorukhkar is a principal at ZS with over a decade of consulting experience in incentive compensation and customer-facing model design. He specializes in designing and administering incentive plans for teams of varying sizes across industries, such as life sciences, financial services, manufacturing, transportation and hospitality.

Deepali Gupta, Associate Principal, Platform and Products, ZS
Deepali brings over 15 years of expertise in strategizing and implementing field performance programs, including ZAIDYN delivery, within the life sciences industry. She currently holds a leadership position in ZAIDYN Commercialization for major life sciences companies, where her primary focus is to assist organizations in meetin their evolving platform and technology requirements through the ZAIDYN platform.

Moderator: Jared Keckeisen, Event Marketing Lead, ZS

How can pharmaceutical companies create standout customer experiences aligned with their strategic imperatives in an era of information overload? In this webinar, ZS experts reveal how AI and advanced analytics are reshaping omnichannel engagement through dynamic next best action frameworks. By leveraging predictive insights, dynamic content personalization, and real-time optimization under sales and marketing guardrails, organizations are driving measurable improvements in brand performance, HCP engagement and patient outcomes. Join us as we explore how leading companies are navigating this transformative landscape—and discuss the implications of generative AI in elevating digital pharma experiences.

Speakers:
Omer Hancer, Principal - ZS
Praveen Chaudhary, Associate Principal – ZS

Moderator:
Jared Keckeisen, Senior Event Marketing Associate - ZS

Better understanding of content and content insights are moving the vision of transforming and optimizing the content supply chain closer to reality. Learn how to lead your organization toward a data- driven approach to marketing using the “right content” with Kate Greengrove, head of U.S. commercial strategic operations and capabilities, GSK, and Kumar Saurabh, global lead for content transformation, ZS.

They’ll discuss how companies can:

• Start small and bring incremental changes to the current ways of working
• Use data and insights to create and use high-performing content
• Predict content engagement even before deployment to enable better content planning .

Pharma spends nearly $4 billion a year on direct-to-consumer (DTC) advertising with no signs of slowing down. Yet, many pharma companies still struggle to analyze and optimize linear TV and digital marketing because they don’t know which components most effectively drive patient behavior and impact sales. By linking TV and digital ad exposure to health data in a privacy-safe way, clients can customize metrics to measure real world health actions and ultimately ROI.

In this webinar, we will demonstrate closed-loop measurement success through a client’s experience analyzing a specific TV campaign’s reach to a qualified audience and the campaign’s success in prompting action (for example: visiting a doctor, scheduling a screening, getting a script for the brand, etc.). Attendees will learn from this real-world example how closed-loop measurement provides best practices for directly measuring an advertisement’s impact on the patient journey and collaborating with creative and media agencies.

Presenters:

• Greg Fry, Patient and Consumer Marketing Analytics, ZS Associates